Hints and tips:
...The stocks of vaccine makers China National Medicines Corp, CanSino Biologics and Walvax Biotechnology remained flat....
...Soriot’s, contrary to popular belief at the time, was quite good: Astra had interesting biologics and oncology prospects....
...(FT) South Korean drugmaker Samsung Biologics will begin producing the Moderna coronavirus vaccine....
...There has been a dearth of big biopharmaceutical IPOs in South Korea since Samsung Biologics raised $1.9bn in 2016 and its rival Celltrion Healthcare raised $858m in 2017....
...Samsung BioLogics is 75 per cent owned by Samsung Electronics and Samsung C&T, the group’s de facto holding company....
...The listing on Seoul’s main board will be the country’s second-largest behind the Won4.9tn listing of Samsung Life Insurance in 2010, and eclipsing the Won2.25tn raised by Samsung Biologics last November...
...its order target of Won6tn next year, noting that it recently won a raft of big overseas orders to build petrochemical plants in Malaysia and the US as well as a Won850bn contract from affiliate Samsung Biologics...
...Amgen, founded in 1980, is one of the four cornerstone groups of the US biotech sector, along with Celgene, Gilead and Biogen, and is credited with developing some of the first successful “biologic” drugs...
...Cheil and its sibling Samsung C&T (which owns 5 per cent of Biologics) have proposed a merger....
...The new company will also be the majority shareholder of Samsung Biologics, producer of the biopharmaceutical drugs that Samsung views as a long-term growth area....
...As part of that strategy, the sale of a 51 per cent stake in its non-core biologics business announced on Wednesday makes sense....
...Fujifilm agreed to buy BioManufacturing Network Diosynth RTP of North Carolina, and MSD Biologics (UK) of Britain, Fujifilm said on Monday....
...Karen Midthun, acting director of the FDA’s centre for biologics evaluation and research, said in a statement: “The availability of Provenge provides a new treatment option for men with advanced prostate...
...Jeff Kindler, chief executive, told the FT: “We now have a more diversified company with vaccines, biologics, nutrition, small and large molecules across the developing and developed worlds....
...Most of these restructuring charges relate to a decision in February to axe 230 research jobs in the US and Ireland, and postpone the construction of a “biologics” drug factory in Ireland....
...And in biopharmaceuticals, an area that dovetails with the process industries cluster, key companies include Billingham-based Avecia Biologics, founded in 1999 following a split from AstraZeneca, and Cambridge...
...healthcare companies which have a presence in the Thames Valley is long and includes: Eli Lilly, Baxter Healthcare, GE Healthcare, Johnson & Johnson, UCB, Abbot Laboratories, Boehringer Ingelheim, Lonza Biologics...
...Biologics have a somewhat better success rate than small molecule drugs, but they remain far from a sure bet....
...Third, we need to introduce generic biologic drugs into the marketplace. These are drugs used to treat illnesses like anemia....
International Edition